Study of Studies Finds Retractions in Drug Literature Often Indicative of Misconduct

The Takeaway

In January 2003, The Lancet – one of the world’s oldest and most respected medical journals – published an article championing the combination of two drugs (ACE inhibitors and ARBs) in treating certain types of kidney disease. More than 100,000 patients were prescribed these two drugs in combination.
But then an investigation concluded that the data in the study had been collected in a way that made it scientifically unsound. The Lancet printed a retraction, but thousands of patients still receive these drugs in combination.
This is just one case of several explored in a new study of studies by researchers at the University of Illinois at Chicago. They found that nearly three quarters of retracted drug studies were retracted because of scientific misconduct like falsified data and plagiarism.  Simon Pickard  is the senior author of the study.  Art Caplan  is a professor of medical ethics and health policy at the University of Pennsylvania.

Kickstart The World’s fundraising drive!

The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.

Make a gift today to help us raise $67,000  by the end of the year and keep The World going strong. Every gift will get us one step closer to our goal!